Chapter: Pharmacology of Beta Blockers

Learning Objectives

By the end of this chapter, the student should be able to:

• define beta blockers
• classify beta blockers
• explain the mechanism of action of beta blockers
• describe the pharmacological effects on various organ systems
• discuss therapeutic uses, adverse effects, contraindications, and precautions
• differentiate selective and non-selective beta blockers
• answer common viva and theory questions on beta blockers

1. Introduction

Beta blockers, also called β-adrenergic antagonists or β-adrenoceptor blockers, are drugs that block the actions of catecholamines such as adrenaline and noradrenaline on beta-adrenergic receptors.

They are among the most important drugs in cardiovascular pharmacology and are widely used in:

• hypertension
• angina pectoris
• myocardial infarction
• arrhythmias
• heart failure
• glaucoma
• thyrotoxicosis
• migraine prophylaxis
• essential tremor
• portal hypertension

Beta blockers are high-yield drugs in MBBS because they connect autonomic pharmacology with cardiology, medicine, ophthalmology, and endocrinology.

2. Adrenergic Receptors Relevant to Beta Blockers

2.1 Beta-1 receptors

Located predominantly in:

• heart
• juxtaglomerular cells of kidney

2.1.1 Stimulation causes

• increased heart rate
• increased force of contraction
• increased AV conduction
• increased renin release

2.2 Beta-2 receptors

Located predominantly in:

• bronchial smooth muscle
• vascular smooth muscle
• uterus
• liver
• skeletal muscle

2.2.1 Stimulation causes

• bronchodilation
• vasodilation
• uterine relaxation
• glycogenolysis
• tremor

2.3 Beta-3 receptors

Located mainly in:

• adipose tissue
• urinary bladder

These are less important in classical MBBS discussions of beta blockers.

3. Definition

Beta blockers are drugs that competitively antagonize beta-adrenergic receptors, thereby reducing the effects of sympathetic stimulation on target organs.

4. Classification of Beta Blockers

Beta blockers may be classified in several ways.

4.1 According to receptor selectivity

4.1.1 Non-selective beta blockers

Block both β1 and β2 receptors.

Examples:

• Propranolol
• Nadolol
• Timolol
• Pindolol

4.1.2 Cardioselective beta blockers

Preferentially block β1 receptors.

Examples:

• Atenolol
• Metoprolol
• Bisoprolol
• Esmolol
• Betaxolol
• Nebivolol

4.2 According to presence of intrinsic sympathomimetic activity (ISA)

These drugs partially stimulate beta receptors while blocking stronger catecholamine effects.

Examples:

• Pindolol
• Acebutolol

They are less commonly emphasized in routine clinical use today.

4.3 According to additional vasodilator action

Examples:

• Carvedilol → also blocks α1 receptors
• Labetalol → blocks β and α1 receptors
• Nebivolol → enhances nitric oxide-mediated vasodilation

4.4 According to lipid solubility

4.4.1 Highly lipid-soluble

• Propranolol
• Metoprolol

4.4.2 Less lipid-soluble / hydrophilic

• Atenolol

This affects CNS penetration and pharmacokinetics.

5. Classification Table

Class	Drugs	Main Feature
Non-selective	Propranolol, Timolol, Nadolol, Pindolol	block β1 and β2
β1-selective	Atenolol, Metoprolol, Bisoprolol, Esmolol, Betaxolol, Nebivolol	mainly block β1
With ISA	Pindolol, Acebutolol	partial agonist property
Mixed α + β blockers	Labetalol, Carvedilol	vasodilator effect also
Ultra-short acting	Esmolol	very short duration

6. Mechanism of Action

Beta blockers competitively inhibit catecholamines at beta receptors.

6.1 In the heart

Blocking β1 receptors produces:

• decreased heart rate (negative chronotropic effect)
• decreased force of contraction (negative inotropic effect)
• decreased AV conduction (negative dromotropic effect)
• reduced cardiac output

6.2 In the kidney

Blocking β1 receptors in juxtaglomerular cells reduces:

• renin secretion
• angiotensin II formation
• aldosterone secretion indirectly

This contributes to the antihypertensive action.

6.3 In the eye

Beta blockers reduce aqueous humor production, lowering intraocular pressure.

6.4 In other tissues

Non-selective beta blockers can block β2 receptors and produce:

• bronchoconstriction
• peripheral vasoconstriction in some patients
• impaired glycogenolysis
• masking of hypoglycemia

7. Pharmacological Actions

7.1 Cardiovascular system

This is the most important section.

7.1.1 Effects

• decrease heart rate
• decrease myocardial contractility
• decrease cardiac output
• decrease blood pressure
• reduce myocardial oxygen demand
• suppress arrhythmias
• reduce renin release

7.1.2 Clinical significance

These effects explain use in:

• hypertension
• angina
• arrhythmias
• post-myocardial infarction states
• chronic heart failure

7.2 Blood pressure

Beta blockers lower blood pressure by:

• reducing cardiac output
• inhibiting renin release
• decreasing sympathetic outflow in some cases

Initially, peripheral resistance may not fall much, but with long-term use BP decreases.

7.3 Respiratory system

Non-selective beta blockers block β2 receptors in bronchi, causing:

• bronchoconstriction
• increased airway resistance

7.3.1 Important point

This is why non-selective beta blockers are contraindicated in bronchial asthma.

7.4 Eye

Beta blockers such as timolol decrease aqueous humor formation and lower intraocular pressure.

7.4.1 Use

• glaucoma

7.5 CNS

Especially lipid-soluble beta blockers may cause:

• sedation
• fatigue
• depression
• nightmares
• sleep disturbance

Propranolol crosses the blood-brain barrier relatively well.

7.6 Metabolic effects

Non-selective beta blockers may:

• inhibit glycogenolysis
• prolong recovery from hypoglycemia
• mask adrenergic warning signs of hypoglycemia such as tachycardia and tremor
• alter lipid profile slightly in some cases

This is important in diabetic patients.

7.7 Skeletal muscle

Beta blockers may reduce:

• tremors

Hence propranolol is useful in essential tremor and in tremor associated with anxiety or thyrotoxicosis.

8. Pharmacokinetics

8.1 Absorption

Most beta blockers are well absorbed orally.

8.2 First-pass metabolism

Some drugs like propranolol undergo significant first-pass metabolism.

8.3 Distribution

Lipid-soluble drugs enter the CNS more easily.

8.4 Elimination

• Atenolol is mainly renally excreted
• Propranolol is mainly hepatically metabolized
• Esmolol is rapidly metabolized by esterases in red blood cells

8.5 Duration

• Esmolol is ultra-short acting
• Atenolol and nadolol have longer duration

9. Therapeutic Uses of Beta Blockers

9.1 Hypertension

Beta blockers reduce blood pressure mainly by:

• decreasing cardiac output
• decreasing renin release

They are especially useful when hypertension is associated with:

• angina
• previous myocardial infarction
• tachyarrhythmia
• heart failure

9.2 Angina pectoris

Beta blockers reduce:

• heart rate
• contractility
• blood pressure

Thus they reduce myocardial oxygen demand, making them useful in chronic stable angina.

9.2.1 Important note

They are not first choice in vasospastic angina, where they may worsen spasm.

9.3 Myocardial infarction

Beta blockers are useful:

• during and after MI in selected patients
• for secondary prevention after MI

9.3.1 Benefits

• reduce arrhythmias
• reduce myocardial oxygen demand
• improve survival in appropriate patients

9.4 Cardiac arrhythmias

Useful particularly in:

• supraventricular tachycardia
• atrial fibrillation rate control
• atrial flutter rate control
• some ventricular arrhythmias
• arrhythmias due to catecholamine excess

9.4.1 Examples

• Metoprolol
• Esmolol
• Propranolol

9.5 Chronic heart failure

Certain beta blockers improve survival in chronic heart failure when carefully introduced.

9.5.1 Important drugs

• Metoprolol
• Bisoprolol
• Carvedilol

9.5.2 Important exam point

Although beta blockers reduce cardiac contractility acutely, long-term controlled use improves outcomes in chronic heart failure.

9.6 Glaucoma

Topical beta blockers such as timolol reduce intraocular pressure by decreasing aqueous humor secretion.

9.7 Thyrotoxicosis

Propranolol is useful because it:

• relieves tachycardia, tremor, anxiety
• partially inhibits peripheral conversion of T4 to T3 at high doses

9.8 Migraine prophylaxis

Beta blockers, especially propranolol, are used to prevent recurrent migraine attacks.

9.9 Essential tremor

Propranolol reduces tremor amplitude.

9.10 Performance anxiety

Propranolol may be used to reduce autonomic symptoms such as:

• tachycardia
• tremor
• palpitations

9.11 Pheochromocytoma

Beta blockers may be used only after adequate alpha blockade to control tachycardia.

9.11.1 Important point

Never give beta blocker alone before alpha blockade in pheochromocytoma, because unopposed alpha stimulation may cause severe hypertension.

9.12 Portal hypertension

Non-selective beta blockers such as propranolol may reduce portal pressure and are used in prevention of variceal bleeding.

10. Summary Table of Therapeutic Uses

Use	Common Drugs
Hypertension	Atenolol, Metoprolol, Bisoprolol, Labetalol
Angina	Propranolol, Atenolol, Metoprolol
Post-MI	Metoprolol, Propranolol, Bisoprolol
Arrhythmias	Esmolol, Metoprolol, Propranolol
Heart failure	Bisoprolol, Metoprolol, Carvedilol
Glaucoma	Timolol, Betaxolol
Thyrotoxicosis	Propranolol
Migraine prophylaxis	Propranolol
Essential tremor	Propranolol
Portal hypertension	Propranolol, Nadolol
Hypertensive emergencies in pregnancy	Labetalol

11. Adverse Effects of Beta Blockers

11.1 Common adverse effects

• bradycardia
• hypotension
• fatigue
• weakness
• cold extremities
• dizziness
• exercise intolerance

11.2 Cardiovascular adverse effects

• excessive bradycardia
• AV block
• worsening of acute heart failure
• severe hypotension

11.3 Respiratory adverse effects

Especially with non-selective drugs:

• bronchospasm
• aggravation of asthma

11.4 CNS adverse effects

More common with lipid-soluble drugs:

• depression
• nightmares
• sleep disturbances
• mental fatigue

11.5 Metabolic adverse effects

• masking of hypoglycemia
• delayed recovery from hypoglycemia
• possible adverse lipid changes

11.6 Sexual dysfunction

May occur in some patients.

12. Contraindications

Beta blockers are contraindicated or used with extreme caution in:

• bronchial asthma
• severe bradycardia
• AV block
• cardiogenic shock
• acute decompensated heart failure
• severe peripheral vascular disease
• variant angina in some settings
• uncontrolled diabetes with frequent hypoglycemia, with caution rather than absolute contraindication

13. Precautions

Use carefully in:

• diabetes mellitus
• COPD/asthma
• peripheral vascular disease
• depression
• elderly patients
• liver or kidney disease depending on the drug

14. Abrupt Withdrawal

A very important exam point.

Sudden withdrawal of beta blockers may cause:

• rebound tachycardia
• worsening angina
• arrhythmias
• myocardial infarction in high-risk patients

14.1 Reason

Chronic beta blockade may cause receptor upregulation; abrupt stoppage exposes the heart to catecholamine excess.

14.2 Rule

Beta blockers should be tapered gradually, not stopped abruptly.

15. Drug Interactions

15.1 With verapamil or diltiazem

May cause:

• marked bradycardia
• AV block
• heart failure

15.2 With insulin or oral antidiabetic drugs

May mask hypoglycemia.

15.3 With other antihypertensives

May cause additive hypotension.

15.4 With digoxin

Risk of excessive bradycardia or AV conduction problems may increase.

15.5 In pheochromocytoma

Beta blocker should not be given before alpha blockade.

16. Comparison of Important Beta Blockers

Drug	Selectivity	Special Feature	Main Uses
Propranolol	non-selective	highly lipid-soluble	angina, migraine, tremor, thyrotoxicosis
Atenolol	β1-selective	hydrophilic, longer acting	hypertension, angina
Metoprolol	β1-selective	commonly used in CV disease	HTN, angina, MI, HF
Bisoprolol	β1-selective	important in heart failure	HTN, HF
Esmolol	β1-selective	ultra-short acting IV	acute arrhythmias, perioperative control
Timolol	non-selective	topical use in eye	glaucoma
Carvedilol	non-selective + α1 block	vasodilator	heart failure, hypertension
Labetalol	non-selective + α1 block	useful in hypertensive emergencies	HTN, pregnancy HTN
Nebivolol	β1-selective	nitric oxide-mediated vasodilation	hypertension

17. Selective vs Non-Selective Beta Blockers

Feature	β1-selective	Non-selective
Receptors blocked	mainly β1	β1 and β2
Bronchospasm risk	lower	higher
Use in asthma	relatively safer, but still cautious	generally avoided
Examples	Atenolol, Metoprolol, Bisoprolol	Propranolol, Timolol, Nadolol

17.1 Important note

Selectivity is dose-dependent. At high doses, even β1-selective drugs may block β2 receptors.

18. Beta Blockers with ISA

Some beta blockers have partial agonist activity.

Examples:

• Pindolol
• Acebutolol

18.1 Effects

• less resting bradycardia
• less reduction in cardiac output at rest

18.2 Clinical note

They are not commonly preferred after MI.

19. Beta Blockers in Special Conditions

19.1 In asthma

Avoid non-selective beta blockers.

19.2 In diabetes

Can mask tachycardia and tremor due to hypoglycemia.

19.3 In heart failure

Useful only selected agents and only under careful supervision.

19.4 In pregnancy

Labetalol is commonly used in hypertensive disorders of pregnancy.

20. Mnemonics

20.1 Main action of beta blockers

“Beta blockers bring the beat below.”
They reduce heart rate and cardiac workload.

20.2 Non-selective example

“Propranolol is Pro at blocking both.”
Blocks both β1 and β2.

20.3 β1-selective drugs

“A-M-BE-N are heart-friendly”

• Atenolol
• Metoprolol
• Bisoprolol
• Esmolol
• Nebivolol

20.4 Glaucoma drug

“TIME lowers eye pressure”

• TIMolol in the EYE

20.5 Contraindication

“Beta block the bronchi too”
Think asthma with non-selective drugs.

20.6 Special uses of propranolol

“Propranolol Protects in Pressure, Pulse, Panic, and Prophylaxis”

• blood pressure
• pulse control
• performance anxiety
• migraine prophylaxis

21. High-Yield Exam Points

• Beta blockers are competitive antagonists at beta receptors.
• β1 blockade decreases heart rate, force, AV conduction, and renin release.
• Non-selective beta blockers can cause bronchospasm.
• Propranolol is a non-selective beta blocker.
• Atenolol and metoprolol are β1-selective.
• Esmolol is ultra-short acting.
• Timolol is used topically in glaucoma.
• Propranolol is useful in thyrotoxicosis, essential tremor, and migraine prophylaxis.
• Certain beta blockers improve survival in chronic heart failure.
• Beta blockers should not be stopped abruptly.
• In pheochromocytoma, beta blockade should only follow alpha blockade.

22. Viva Questions and Answers

22.1 Short viva questions

1. What are beta blockers?
They are drugs that block beta-adrenergic receptors and inhibit the effects of catecholamines.

2. Name one non-selective beta blocker.
Propranolol.

3. Name two cardioselective beta blockers.
Atenolol and metoprolol.

4. What is the effect of β1 blockade on the heart?
Decreased heart rate, contractility, and conduction.

5. How do beta blockers lower blood pressure?
By reducing cardiac output and suppressing renin release.

6. Why are non-selective beta blockers contraindicated in asthma?
Because they block β2 receptors and cause bronchoconstriction.

7. Which beta blocker is used in glaucoma?
Timolol.

8. Which beta blocker is ultra-short acting?
Esmolol.

9. Which beta blocker is used in thyrotoxicosis?
Propranolol.

10. Which beta blocker is useful in chronic heart failure?
Bisoprolol, metoprolol, or carvedilol.

11. Why should beta blockers not be stopped abruptly?
Because abrupt withdrawal can cause rebound tachycardia, angina, and arrhythmias.

12. Which beta blocker is commonly used in hypertensive disorders of pregnancy?
Labetalol.

13. What is ISA?
Intrinsic sympathomimetic activity.

14. Name one beta blocker with ISA.
Pindolol.

15. Why should beta blockers be used cautiously in diabetes?
They may mask symptoms of hypoglycemia.

22.2 Long viva questions

1. Classify beta blockers and describe their mechanism of action.

2. Write a detailed note on propranolol.

3. Discuss the pharmacological actions and therapeutic uses of beta blockers.

4. Compare selective and non-selective beta blockers.

5. Write the adverse effects and contraindications of beta blockers.

23. Short Notes for University Exams

23.1 Short note: Propranolol

Propranolol is a non-selective beta blocker that blocks both β1 and β2 receptors. It decreases heart rate, myocardial contractility, AV conduction, and renin release. It is used in hypertension, angina, arrhythmias, thyrotoxicosis, migraine prophylaxis, and essential tremor. Adverse effects include bradycardia, bronchospasm, fatigue, and CNS effects. It is contraindicated in asthma.

23.2 Short note: Cardioselective beta blockers

Cardioselective beta blockers preferentially block β1 receptors in the heart. Examples include atenolol, metoprolol, bisoprolol, and esmolol. They are mainly used in cardiovascular diseases and are relatively safer than non-selective drugs in patients with airway disease, though caution is still needed.

23.3 Short note: Timolol

Timolol is a non-selective beta blocker used topically in glaucoma. It lowers intraocular pressure by decreasing aqueous humor production. It can still be systemically absorbed and may cause bradycardia or bronchospasm.

24. One-Page Revision Table

Topic	Key Point
Main action	block beta receptors
β1 effect	↓ HR, ↓ contractility, ↓ renin
Non-selective example	propranolol
β1-selective examples	atenolol, metoprolol, bisoprolol
Ultra-short acting	esmolol
Eye use	timolol in glaucoma
HF drugs	metoprolol, bisoprolol, carvedilol
Thyrotoxicosis drug	propranolol
Main danger in asthma	bronchospasm
Withdrawal	taper gradually

25. Conclusion

Beta blockers are among the most important drugs in clinical pharmacology. Their principal action is blockade of beta-adrenergic receptors, especially β1 receptors in the heart and kidney. This produces beneficial effects in hypertension, angina, arrhythmias, myocardial infarction, and heart failure. However, their use requires care because they may cause bradycardia, bronchospasm, and metabolic disturbances. A strong understanding of their classification, mechanisms, uses, and contraindications is essential for MBBS students.

26. Rapid Recall Box

• Beta blockers → block beta receptors
• β1 blockade → ↓ HR, ↓ force, ↓ renin
• Propranolol → non-selective
• Atenolol / Metoprolol / Bisoprolol → β1-selective
• Esmolol → ultra-short acting
• Timolol → glaucoma
• Carvedilol / Labetalol → α + β blockers
• Main adverse effects → bradycardia, bronchospasm, fatigue
• Never stop abruptly